
Reset all filters
01 4Mikeluna Combination Ophthalmic Solution
Carteolol Hydrochloride, Latanoprost
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 44
2020 Revenue in Millions : 38
Growth (%) : 24
Carteolol Hydrochloride, Latanoprost
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 47
2021 Revenue in Millions : 44
Growth (%) : 7
Carteolol Hydrochloride, Latanoprost
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 46
2022 Revenue in Millions : 47
Growth (%) : 11
Carteolol Hydrochloride, Latanoprost
Main Therapeutic Indication : Ophthalmology
Currency : USD
2024 Revenue in Millions : 48
2023 Revenue in Millions : 46
Growth (%) : 5